The 3rd Gordon Research Seminar on Cancer Nanotechnology will bridge nanotechnology research with translational pre-clinical cancer research. Graduate students, post-docs, and other early-career scientists will have the chance to present their cutting-edge ideas and unpublished data, as well as network with peers in an engaging environment.
Nanotechnology offers exciting opportunities in the battle against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. The 2021 GRS will provide an overview of emerging cancer-related nanotechnologies from the bench to the bedside. By bringing together exceptional scientists representing clinical, biological, and physical sciences, we will gain new insights into the interface of bio-nano science and cancer nanotechnology.
The seminar will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS, either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The seminar chair will select speakers from abstracts submitted by March 12, 2021. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Information section above.
Gordon Research Seminars are 2-day meetings which take place on the Saturday and Sunday just prior to the start of the associated GRC. The GRS opens with a 1-hour introductory session on Saturday afternoon, followed by a poster session, dinner and a 2-hour session in the evening. Sunday morning begins with breakfast and is followed by another 2-hour session, a second poster session, and lunch. A final 1-hour session takes place just after lunch, and the associated GRC begins later that evening.